Diseases Non-Hodgkin's Lymphoma Guidelines Further reading Medline Papers Other resources Trials Contact form Print this page Bookmark this page Send to friend Diseases Non-Hodgkin Lymphoma Papers Full text available The following papers are all listed within the Medline database as being available as a free download (full text) from the web. If any of them are not so available, please do not contact the Fund as we do not control the content of Medline. Last updated 02/10/2008 Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas Cilley, J. and Winter, J. N. Haematologica 91 2006 113-120 Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece Campo, E., Chott, A., Kinney, M. C., Leoncini, L., Meijer, C. J., Papadimitriou, C. S., Piris, M. A., Stein, H., and Swerdlow, S. H. Histopathology 48 2006 481-504 Current status and perspective of antibody therapy in follicular lymphoma Buske, C., Weigert, O., Dreyling, M., Unterhalt, M., and Hiddemann, W. Haematologica 91 2006 104-112 Diffuse Large B-Cell Lymphoma: Risk Stratification and Management of Relapsed Disease John W. Sweetenham Hematology (Am.Soc.Hematol Educ.Program) 2005 252-259 Biology and Treatment of Epstein-Barr Virus–Associated Non-Hodgkin Lymphomas Helen E. Heslop Hematology (Am.Soc.Hematol Educ.Program) 2005 260-266 Aggressive Peripheral T-Cell Lymphomas (Specified and Unspecified Types) Kerry J. Savage Hematology (Am.Soc.Hematol Educ.Program) 2005 267-277 Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas Randy D. Gascoyne Hematology (Am.Soc.Hematol Educ.Program) 2005 299-306 Clinical Presentation and Management of Marginal Zone Lymphomas Catherine Thieblemont Hematology (Am.Soc.Hematol Educ.Program) 2005 307-313 Biology and Management of Histologic Transformation of Indolent Lymphoma Arnold S. Freedman Hematology (Am.Soc.Hematol Educ.Program) 2005 314-320 Multimodality Therapies and Optimal Schedule of Antibodies: Rituximab in Lymphoma as an Example Michele Ghielmini Hematology (Am.Soc.Hematol Educ.Program) 2005 321-328 Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody Therapy Jonathan W. Friedberg Hematology (Am.Soc.Hematol Educ.Program) 2005 329-334 Targeting CD20 in Follicular NHL: Novel Anti-CD20 Therapies, Antibody Engineering, and the Use of Radioimmunoconjugates John P. Leonard Hematology (Am.Soc.Hematol Educ.Program) 2005 335-339 Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation Knight, C., Hind, D., Brewer, N., and Abbott, V. Health Technol.Assess. 8 2004 iii, ix-82 Pesticide product use and risk of non-Hodgkin lymphoma in women Kato, I., Watanabe-Meserve, H., Koenig, K. L., Baptiste, M. S., Lillquist, P. P., Frizzera, G., Burke, J. S., Moseson, M., and Shore, R. E. Environ.Health Perspect. 112 2004 1275-1281 Ultraviolet radiation and incidence of non-Hodgkin's lymphoma among Hispanics in the United States Hu, S., Ma, F., Collado-Mesa, F., and Kirsner, R. S. Cancer Epidemiol.Biomarkers Prev. 13 2004 59-64 Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma Horwitz, S. M., Negrin, R. S., Blume, K. G., Breslin, S., Stuart, M. J., Stockerl-Goldstein, K. E., Johnston, L. J., Wong, R. M., Shizuru, J. A., and Horning, S. J. Blood 103 1-2-2004 777-783 Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications Clarke, C. A., Glaser, S. L., Dorfman, R. F., Bracci, P. M., Eberle, E., and Holly, E. A. Cancer Epidemiol.Biomarkers Prev. 13 2004 138-143 Treatment of malignant lymphoma Berthold, D. and Ghielmini, M. Swiss.Med Wkly. 134 21-8-2004 472-480 Primary gastric lymphoma Al Akwaa, A. M., Siddiqui, N., and Al Mofleh, I. A. World J Gastroenterol. 10 2004 5-11 Clinical mimics of lymphoma Brown,J.R. and Skarin,A.T. The Oncologist 9 2004 406-416 What is new in lymphoma? Cheson,B.D. CA A Cancer Journal for Clinicians 54 2004 260-272 Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance Cohen, Y., Solal-Celigny, P., and Polliack, A. Haematologica 88 2003 811-23, Lymphoma of the skin Connors, J. M., Hsi, E. D., and Foss, F. M. Hematology (Am.Soc.Hematol Educ.Program.) 2002 263-82, Therapy for stage I aggressive non-Hodgkin's lymphoma Kluin-Nelemans, H. C. Croat.Med.J 43 2002 546-9, Progress and promise in the treatment of indolent lymphomas McLaughlin, P. Oncologist 7 2002 217-25, Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines Ruffini, P. A., Neelapu, S. S., Kwak, L. W., and Biragyn, A. Haematologica 87 2002 989-1001, Update on epidemiology and therapeutics for non-Hodgkin's lymphoma Vose, J. M., Chiu, B. C., Cheson, B. D., Dancey, J., and Wright, J. Hematology (Am.Soc.Hematol Educ.Program.) 2002 241-62, Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma: a systematic review and economic evaluation Wake, B., Hyde, C., Bryan, S., Barton, P., Song, F., Fry-Smith, A., and Davenport, C. Health Technol.Assess. 6 2002 1-85, MALT Lymphomas Cavalli, F., Isaacson, P. G., Gascoyne, R. D., and Zucca, E. Hematology (Am.Soc.Hematol Educ.Program.) 2001 241-58, Current treatment of Cutaneous T-Cell Lymphoma Duvic, M. Dermatol.Online.J 7 2001 3, T cell and NK cell lymphoproliferative disorders Greer, J. P., Kinney, M. C., and Loughran, T. P., Jr. Hematology (Am.Soc.Hematol Educ.Program.) 2001 259-81, Medline searches It is not possible to list all papers on this topic. The Medline link in the menu at the left will open a page which will allow you to search Medline for all papers on this topic, for all papers on a specific aspect of this topic or to apply limits to either of these searches to ensure a manageable number of responses. Because Medline contains many millions of papers, an unrestricted search may return a huge number of hits. It is advised that you carry out searches limited to the last 6 to 12 months initially as you can easily repeat the search with no limits.

privacy | disclaimer Registered charity 216032 (England & Wales) SC037529 (Scotland) Limited Company 738089 © Leukaemia Research Fund 2008    We subscribe to the HONcode principles of the Health On The Net Foundation.